Skip to main content

Search
News

Seattle biotech's rare approach takes cancer fight to next level

|

Seattle biotech's rare approach takes cancer fight to next level

May 28, 2014

http://www.king5.com/health/Seattle-Juno-Therapeutics-cancer-fight--260931231.html

 

Source - KING 5 TV


Medical research institutions may all target the same maladies, but they regularly compete with each other over talent and funding. So how unusual is it for three of the country's top cancer research facilities to combine their efforts to form a biotech startup company? "It is relatively rare to bring three institutions of that caliber together to collaborate rather than to compete," said Hans Bishop, CEO and co-founder of Juno Therapeutics. It's now his job to help build a business model for Juno, and commercialize the lab work that Fred Hutchinson Cancer Research Center, Seattle Children's Research Institute and New York's Memorial Sloan Kettering are pursuing in immunotherapy.

Press Contacts for Media Interviews

Email for Media Interviews
press@seattlechildrens.org
Phone for Media Interviews
206-987-4500
Monday through Friday
8:30 a.m. to 5:30 p.m. Pacific time (non-holidays)
Urgent After Hours for Media Interviews
206-987-2000
Call switchboard to page Media Relations staff on call

Latest News

Doctor’s Advice: How to enjoy the hot weather safely
7.11.14 — Q13 Fox

Dr. Tony Woodward, medical director of emergency services at Seattle Children’s, discusses how to enjoy the hot weekend weather ... cont.

Teen Patient Gives MTV-Style Tour Of Seattle Children's Hospital
7.11.14 — Evening Magazine

A local teenager is using the “MTV Cribs” show format to show off an unlikely place: Seattle Children’s Hospital. This is the ... cont.

Seattle Scientist Trying To Disrupt HPV, Which Hacks Your Cells To Cause Cancer
7.11.14 — KPLU Radio

Most sexually-active people will pick up human papillomavirus at one time or another, and it’s very dangerous for a small ... cont.